Nutrition

Intermittent Fasting: What 62 Studies Actually Reveal About What Works

By Health 656 Editorial Team 2026-04-10 10 min read

Clock and plate of healthy food representing time-restricted eating

Intermittent fasting (IF) has gone from fringe to fitness gospel in a decade. But what does the actual evidence say? A 2022 umbrella review in Diabetes & Metabolic Syndrome analyzed 62 randomized controlled trials covering more than 6,500 participants and found IF produced an average weight loss of 3 to 8% over 8 to 24 weeks — roughly equivalent to traditional calorie restriction. A 2023 NEJM trial of 139 adults with obesity showed time-restricted eating (TRE) was no better than calorie counting alone for weight loss. Yet IF clearly improves insulin sensitivity, blood pressure, and inflammatory markers in many people. Here's what the evidence shows works — and who should skip it.

16:8 vs. 5:2 vs. ADF — Which Protocol Wins?

The most popular protocol is 16:8 time-restricted eating: eat within an 8-hour window, fast for 16. A 2020 JAMA Internal Medicine trial (TREAT study) found 16:8 produced 0.94 kg of weight loss over 12 weeks — modest but significant. A 2022 follow-up showed earlier eating windows (8 a.m. to 4 p.m.) outperformed later ones for glycemic control.

5:2 fasting involves eating normally 5 days per week and restricting to 500 to 600 calories on 2 non-consecutive days. A 2021 Cell Metabolism trial of 100 adults showed 5:2 produced equivalent weight loss to daily calorie restriction (5.3 kg vs. 5.0 kg) but improved adherence by 18%.

Alternate-day fasting (ADF) is the most aggressive — fasting every other day. A 2017 JAMA Internal Medicine 1-year trial found ADF produced 6.0% weight loss vs. 5.3% for daily restriction, but had a much higher dropout rate (38% vs. 29%). Sustainability is the deciding factor for most people.

Beyond Weight Loss — The Metabolic Benefits That Matter

IF's most consistent benefit is improved insulin sensitivity. A 2018 Cell Metabolism trial in prediabetic men using a 6-hour eating window (early TRE) showed insulin sensitivity improved by 30% and beta-cell function improved by 27% — even without weight loss.

Blood pressure also drops. The same trial recorded a 10 mmHg reduction in systolic BP after 5 weeks of early TRE, comparable to many antihypertensive drugs. Triglycerides, LDL, and inflammatory markers like C-reactive protein typically improve by 10 to 20% in 8-week trials.

Cellular repair via autophagy is the most-hyped benefit, but human evidence is thin. A 2019 NEJM review by Dr. Mark Mattson noted that autophagy markers rise after 16 to 24 hours of fasting in animal models, with limited but suggestive human data. The metabolic switch from glucose to ketones happens around hour 12 to 16 in most people.

Who Should NOT Try Intermittent Fasting

Pregnant or breastfeeding women should avoid IF entirely — caloric and nutrient demands are too high. Anyone with a history of eating disorders is at elevated risk; a 2020 Eating Behaviors study found IF was associated with a 60% higher likelihood of disordered eating patterns in college-aged women.

Type 1 diabetics and people on insulin or sulfonylureas face dangerous hypoglycemia risk and should only fast under medical supervision. Those with adrenal dysfunction may also struggle — see our guide on cortisol and HPA axis health.

Premenopausal women may experience hormonal disruption with aggressive protocols. A 2022 Obesity trial found that women fasting more than 14 hours per day for 8 weeks showed reduced DHEA and slight LH disruption. Shorter fasting windows (12 to 14 hours) appear safer for female hormonal health.

The Long-Term Verdict — Is IF Worth It?

Long-term data is finally arriving. A 2024 Annals of Internal Medicine 12-month trial of 90 adults found 8-hour TRE produced 4.61 kg weight loss vs. 4.35 kg for calorie counting — statistically equivalent. Compliance was the deciding factor: 83% of TRE participants stuck with it vs. 76% of counters.

The mortality data is mixed. A controversial 2024 American Heart Association abstract suggested 8-hour TRE was associated with a 91% higher cardiovascular death rate over 8 years — but the data was observational, self-reported, and heavily criticized by methodologists.

Bottom line: IF works for many people because it simplifies eating. If you find it sustainable and feel well, the evidence supports it as a legitimate strategy. If it triggers binging, fatigue, or hormonal issues, traditional calorie balance works just as well.

Common Questions

Is 16:8 fasting actually effective for weight loss?

Yes, but modestly. The 2020 TREAT trial showed about 0.94 kg loss over 12 weeks. It works mainly by reducing daily calorie intake. Earlier eating windows (before 4 p.m.) produce better metabolic results.

Can women do intermittent fasting?

Most women tolerate 12 to 14-hour fasts well. Aggressive protocols beyond 16 hours daily may disrupt hormones in some premenopausal women. Pregnant and breastfeeding women should avoid fasting entirely.

Does fasting trigger autophagy in humans?

Limited human data suggests autophagy markers rise after 16 to 24 hours of fasting, but most evidence comes from animal studies. The metabolic switch from glucose to ketones occurs around 12 to 16 hours in most adults.

intermittent-fasting weight-loss metabolic-health 16-8 time-restricted-eating